Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 17/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | PPARA | Q07869 | 11/20 | 0.40 |
| ▸ | PPARD | Q03181 | 3/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6936011 | 1.00 | PPARG (0.47) | PPARGCYP1A2CYP2D6CYP19A1CYP2C9 | |
| SCHEMBL6939474 | 0.91 | PPARG (0.46) | PPARGCYP1A2CYP2D6CYP19A1CYP2C9 | |
| SCHEMBL6939444 | 0.91 | PPARG (0.46) | PPARGCYP1A2CYP2D6CYP19A1CYP2C9 | |
| SCHEMBL6939476 | 0.91 | PPARG (0.46) | PPARGCYP1A2CYP2D6CYP19A1CYP2C9 | |
| SCHEMBL6936711 | 0.91 | PPARG (0.46) | PPARGCYP1A2CYP2D6CYP19A1CYP2C9 | |
| SCHEMBL6934039 | 0.91 | PPARG (0.43) | PPARGCYP1A2CYP2D6CYP19A1CYP2C9 | |
| SCHEMBL6934037 | 0.91 | PPARG (0.43) | PPARGCYP1A2CYP2D6CYP19A1CYP2C9 | |
| SCHEMBL6933275 | 0.90 | PPARG (0.44) | PPARGCYP1A2CYP2D6CYP19A1CYP2C9 | |
| SCHEMBL6933273 | 0.90 | PPARG (0.44) | PPARGCYP1A2CYP2D6CYP19A1CYP2C9 | |
| SCHEMBL6933889 | 0.86 | PPARG (0.57) | PPARGCYP1A2CYP2D6CYP19A1CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0916651-B1 | PHENYLALKYLCARBOXYLIC ACID DERIVATIVES | SANKYO CO (JP) | 2003-10-15 | — | — | EP | claimed |
| US-6103907-A | ALDOSE REDUCTASE INHIBITING ANTIDIABETIC AGENT | SANKYO COMPANY, LIMITED (JP) | 2000-08-15 | — | — | US | claimed |
| EP-0916651-A1 | PHENYLALKYLCARBOXYLIC ACID DERIVATIVES | Sankyo Company, Limited (JP) | 1999-05-19 | — | — | EP | claimed |
| EP-0916651-B1 | PHENYLALKYLCARBOXYLIC ACID DERIVATIVES | SANKYO CO (JP) | 2003-10-15 | — | — | EP | disclosed |
| US-6103907-A | ALDOSE REDUCTASE INHIBITING ANTIDIABETIC AGENT | SANKYO COMPANY, LIMITED (JP) | 2000-08-15 | — | — | US | disclosed |
| EP-0916651-A1 | PHENYLALKYLCARBOXYLIC ACID DERIVATIVES | Sankyo Company, Limited (JP) | 1999-05-19 | — | — | EP | disclosed |